{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:26:30Z","timestamp":1778617590396,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10517-022-05521-3","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T06:02:55Z","timestamp":1655964175000},"page":"215-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetic Parameters of Oral Pegylated IFN-\u03bb1"],"prefix":"10.1007","volume":"173","author":[{"given":"E. Yu.","family":"Sherstoboev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"Oleinik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. V.","family":"Zhdanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Kikhtenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"Madonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"5521_CR1","unstructured":"Grigoryan SS. Interferon lambda (type 3 interferons) and viral infections. Interferon \u2014 2011. Ershova FI, Narovlyansky AN, eds. Moscow, 2012. P. 63-72. Russian."},{"key":"5521_CR2","unstructured":"Karkischenko NN, Khoron\u2019ko VV, Sergeeva SA, Karkischenko VN. Pharmacokinetics. Dolzhich GI, ed. Rostov-on-Don, 2001. Russian."},{"issue":"5","key":"5521_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18699\/SSMJ20210504.Russian","volume":"41","author":"NA Kikhtenko","year":"2021","unstructured":"Kikhtenko NA, Ilyicheva TN, Durymanov AG, Fursova AZh, Madonov PG. Investigation of the antiviral activity of the recombinant human interferon lambda 1 in human conjunctiva cell culture. Sib. Nauch. Med. Zh. 2021;41(5):31-36. doi: https:\/\/doi.org\/10.18699\/SSMJ20210504.Russian.","journal-title":"Sib. Nauch. Med. Zh."},{"issue":"6","key":"5521_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.30906\/0869-2092-2020-83-6-30-37.Russian","volume":"83","author":"PG Madonov","year":"2020","unstructured":"Madonov PG, Kikhtenko NA, Oleinik LA, Udut VV. Interferon Lambda \u2014 the new representative of pharmacologically active interferons. Eksp. Klin. Farmakol. 2020;83(6):30-37. doi: https:\/\/doi.org\/10.30906\/0869-2092-2020-83-6-30-37.Russian.","journal-title":"Eksp. Klin. Farmakol."},{"issue":"1","key":"5521_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10517-021-05330-0","volume":"172","author":"PG Madonov","year":"2021","unstructured":"Madonov PG, Svyatchenko VA, Legostaev SS, Kikhtenko NA, Kotlyarova AA, Oleinik LA, Baikalov GI. Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2. Bull. Exp. Biol. Med. 2021;172(1):53-56. doi: https:\/\/doi.org\/10.1007\/s10517-021-05330-0","journal-title":"Bull. Exp. Biol. Med."},{"issue":"7","key":"5521_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.30906\/0869-2092-2021-84-7-15-20.Russian","volume":"84","author":"PG Madonov","year":"2021","unstructured":"Madonov PG, Svyatchenko VA, Legostaev SS, Kikhtenko NA, Kotlyarova AA, Oleinik LA, Baikalov GI, Udut VV. Antiviral activity against SARS-CoV-2 of a pharmaceutical substance based on immobilized recombinant human interferon lambda-1. Eksp. Klin. Farmakol. 2021;84(7):15-20. doi: https:\/\/doi.org\/10.30906\/0869-2092-2021-84-7-15-20.Russian.","journal-title":"Eksp. Klin. Farmakol."},{"key":"5521_CR7","volume-title":"Transport Processes and Membrane Digestion in the Small Intestinal Mucosa","author":"ST Metelsky","year":"2007","unstructured":"Metelsky ST. Transport Processes and Membrane Digestion in the Small Intestinal Mucosa. Electrophysiological Model. Moscow, 2007. Russian."},{"key":"5521_CR8","volume-title":"Basics in Pharmacokinetics","author":"II Miroshnichenko","year":"2002","unstructured":"Miroshnichenko II. Basics in Pharmacokinetics. Moscow, 2002. Russian."},{"key":"5521_CR9","doi-asserted-by":"crossref","unstructured":"Petrie A, Sabin C. Medical Statistics at a Glance. Moscow, 2021.","DOI":"10.33029\/9704-5904-1-2021-NMS-1-232"},{"issue":"5","key":"5521_CR10","first-page":"118","volume":"49","author":"VK Piotrovsky","year":"1986","unstructured":"Piotrovsky VK. The method of statistical moments and integral model-independent parameters of pharmacokinetics. Farmakol. Toksikol. 1986;49(5):118-127. Russian.","journal-title":"Farmakol. Toksikol."},{"key":"5521_CR11","unstructured":"Manual for Preclinical Studies of New Pharmacological Substances. Part I, Mironov AN, ed. Moscow, 2012. Russian."},{"issue":"1","key":"5521_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003;4(1):69-77. doi: https:\/\/doi.org\/10.1038\/ni875","journal-title":"Nat. Immunol."},{"issue":"4","key":"5521_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50(4):907-923. doi: https:\/\/doi.org\/10.1016\/j.immuni.2019.03.025","journal-title":"Immunity."},{"issue":"1","key":"5521_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","volume":"4","author":"P Sheppard","year":"2003","unstructured":"Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003;4(1):63-68. doi: https:\/\/doi.org\/10.1038\/ni873","journal-title":"Nat. Immunol."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-022-05521-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-022-05521-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-022-05521-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:49:38Z","timestamp":1744156178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-022-05521-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5521"],"URL":"https:\/\/doi.org\/10.1007\/s10517-022-05521-3","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}